护理干预对肾癌术后重组人干扰素α-2b治疗效果的影响被引量：2

Influence of nursing intervention on patients treated with recombinant interferon α-2b after radical nephrectomy

导出

摘要目的探讨护理干预对肾癌术后重组人干扰素α-2b治疗效果的影响。方法将94例采用根治术治疗的肾癌患者随机分为对照组和干预组,每组47例。所有患者在术后给予重组人干扰素α-2b治疗,在此期间,对照组给予常规护理,干预组在常规护理的基础上给予护理干预。比较两组患者的临床指征改善情况、治疗和护理效果以及术后不良反应的发生情况。结果干预组患者的退热时间、白细胞恢复正常时间和术后住院时间均小于对照组(P<0.05)。干预组患者的术后不良反应发生率为4.3%,低于对照组的17.0%(P<0.05)。干预组和对照组患者治疗和护理的有效率分别为97.9%和93.6%,差异无统计学意义(P>0.05)。结论肾癌根治术后应用重组人干扰素α-2b治疗时,给予患者有效的护理干预,可明显缩短术后治疗时间,改善患者的临床症状,降低不良反应的发生率,值得临床推广。 Objective To investigate the effect of nursing intervention on patients treated with recombinant interferon α-2b（r INFα-2b） after radical nephrectomy.Methods 94 patients after radical nephrectomy were randomly divided into the control group（47 cases） and the intervention group（47 cases）.All of the patients were treated with recombinant human interferon α-2b,the control group was given conventional nursing,while the intervention group was given both conventional nursing and intervention nursing.The clinical effect and adverse reactions of the two groups were observed and compared.Results The time of fever relieving,recovery normal of leukocyte and stay in hospital of the intervention group were less than the control group（P〈0.05）.The incidence of adverse effect of the intervention group and the control group were4.3% and 17.0%,respectively（P〈0.05）.However,the total response rate of the two groups were consistent（97.9% vs 93.6%,P〈0.05）.Conclusion The implementation of nursing intervention on patients giving r INFα-2b after radical nephrectomy can shorten the postoperative time,improve the clinical symptoms and reduce the adverse reactions.

作者王仙凤

机构地区江苏省扬州友好医院综合科

出处《中国肿瘤临床与康复》 2015年第1期95-97,共3页 Chinese Journal of Clinical Oncology and Rehabilitation

关键词护理干预肾肿瘤外科手术重组人干扰素Α-2B Nursing intervention Kidney neoplasms Surgical procedures operative rINFα-2b

分类号 R473.73 [医药卫生—护理学]

引文网络
相关文献

参考文献12

1Filson CP,Banerjee M,Wolf JS,et al.Surgeon characteristics and long-term trends in the adoption of laparoscopic radical nephrectomy[J].J Urol,2011,185:2072-2077.
2White MA,Autorino R,Spana G,et al.Robotic laparoendoscopic single-site radical nephrectomy:surgical technique and comparative outcomes[J].Eur Urol,2011,59:815-822.
3Kates M,Badalato GM,Pitman M,et al.Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less[J].J Urol,2011,186:1247-1253.
4宋洪飞.晚期肾癌根治术后应用干扰素-α的疗效观察[J].武汉大学学报（医学版）,2008,29(3):412-414. 被引量：4
5肖玉洪.肾癌患者不同阶段实施健康教育对术后康复的探讨[J].中国肿瘤临床与康复,2012,19(6):509-511. 被引量：7
6沈宏峰,康璇,李威,余书勇,何耿,黄尉.腹膜后腹腔镜下肾部分切除术和根治性肾切除术治疗小肾癌的临床比较[J].中国肿瘤临床与康复,2013,20(2):179-181. 被引量：10
7Poon SA,Silberstein JL,Chen LY,et al.Trends in partial and radical nephrectomy:an analysis of case logs from certifying urologists[J].J Urol,2013,190:464-469.
8Russo P,Szczech LA,Torres GS,et al.Patient and caregiver knowledge and utilization of partial versus radical nephrectomy:results of a national kidney foundation survey to assess educational needs of kidney cancer patients and caregivers[J].Am J Kidney Dis,2013,61:939-946.
9Yokoyama M,Fujii Y,limura Y,et al.Longitudinal change in renal function after radical nephrectomy in japanese patients with renal cortical tumors[J].J Urol,2011,185:2066-2071.
10赵燕云.LEEP联合重组人干扰素a2b栓治疗宫颈病变疗效观察[J].中国妇幼保健,2009,24(16):2293-2294. 被引量：1

二级参考文献39

1傅光华,赖建平,陈善勤,文小平.经腹膜后腹腔镜单纯性肾切除术的临床应用(附11例报告)[J].中国内镜杂志,2007,13(1):79-80. 被引量：3
2Reich O, Pickel H, Tamussino K et al. Microinvasive carcinoma of the cervix : site of first focus of invasion [ J] . Obstel Gynecol, 2001, 97 (6) : 890.
3Parkin DM,Pisani P,Ferlay J.Estimates of the world-wide incidence of eighteen major cancers in 1985.Int J Cancer,1993,54:594-606.
4Bosch FX,Manos MM,Munoz N,et al.Prevalence of human papillomavirus in cervical cancer:a worldwide perspective.International biological study on cervicalcancer IBSCC Study Group.J Natl Cancer Inst,1995,87:796-802.
5Walboomers JM,Jacobs MV,Manos MM,et al.Human papillomavirus is a necessary cause ofinvasivecervicalcancerworldwide.JPathol,1999,189:12-18.
6Filippova M,Song H,Connolly JL,et al.The huan papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis.J Biol Chem,2002,277(24):21730-21739.
7Crish JF,Bone F,Balasubramainian S,et al.Suprabasal expression to the human papillomavirus type 16 onconproteins in mouse epidermis alters expression of cell cycle regulatory proteins.Carcinogenesis,2000,21 (5):1031-1037.
8Ferenzy A,Franco E.Persistent human papollimavirus infection and cervical neoplasia Lancet Oncol,2002,3(1):11-16.
9Konya J,Dillner J.Immunity to oncogenic human papillomaviruses.Adv Cancer Res,2001,82:205-238.
10Gonzalez DI,Zahn CM,Retzloff M,et al.Recurrence of dysplasia after loop electrosurgical excision procedures with long-term follow-up.Am J Obstet Gynecol,2001,184:315-321.